High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT

NCT03130582 · clinicaltrials.gov ↗
COMPLETED
Status
88
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yang Jun